Tekla Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $2.83M | Hold |
422,281
| – | – | 0.11% | 102 |
|
|
2023
Q1 | $3.73M | Hold |
422,281
| – | – | 0.14% | 87 |
|
|
2022
Q4 | $3.23M | Hold |
422,281
| – | – | 0.12% | 94 |
|
|
2022
Q3 | $3.01M | Buy |
422,281
+84,559
| +25% | +$602K | 0.12% | 98 |
|
|
2022
Q2 | $2.73M | Hold |
337,722
| – | – | 0.11% | 106 |
|
|
2022
Q1 | $4.69M | Hold |
337,722
| – | – | 0.16% | 98 |
|
|
2021
Q4 | $9.48M | Hold |
337,722
| – | – | 0.3% | 72 |
|
|
2021
Q3 | $11.5M | Hold |
337,722
| – | – | 0.37% | 67 |
|
|
2021
Q2 | $13.8M | Hold |
337,722
| – | – | 0.45% | 53 |
|
|
2021
Q1 | $13.6M | Buy |
337,722
+51,709
| +18% | +$2.08M | 0.47% | 58 |
|
|
2020
Q4 | $16.9M | Buy |
286,013
+261,298
| +1,057% | +$15.5M | 0.59% | 49 |
|
|
2020
Q3 | $1.2M | Buy |
+24,715
| New | +$1.2M | 0.05% | 174 |
|